Trial Profile
Anaplerotic Therapy Using Triheptanoin for Patients With Glycogen Storage Disease Type I
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 17 Dec 2021
Price :
$35
*
At a glance
- Drugs Triheptanoin (Primary)
- Indications Glycogen storage disease type I
- Focus Therapeutic Use
- 14 Dec 2021 Status changed from recruiting to completed.
- 25 Aug 2020 Status changed from suspended to recruiting.
- 21 Aug 2020 Status changed from recruiting to suspended.